In probing the involvement of NMUR1 in the COAD immune microenvironment, our study made a significant advance by analyzing single-cell sequencing data from two patients with CRC post-immunotherapy—one non-responder (NR) and one complete responder (CR). Here, NMUR1 is linked to colorectal carcinoma.